No photo of Mark T Reding
Contact Expert

View Scopus Profile

Mark T Reding

1993 …2023

Research output per year

If you made any changes in Pure these will be visible here soon.

Projects

Active

A Phase 3 Open-Label, Single-Arm Study To Evaluate The Efficacy and Safety of BMN 270, an Adeno-Associated Virus Vector Mediated Gene Transfer of Human Factor VIII at a dose of 4E13 vg/kg inHemophilia A Patients with Residual FVIII Levels

Reding, M. T.

BIOMARIN PHARMACEUTICAL, INC.

7/15/18 → 7/15/23

Project: Research project

Health Resources and Services Administration Grant

Reding, M. T.

Fairview Health Services

6/1/18 → 5/31/20

Project: Research project

A Phase 3 Open-Label, Single-Arm Study To Evaluate The Efficacy and Safety of BMN 270, an Adeno-Associated Virus Vector-Mediated Gene Transfer of Human Factor VIII in Hemophilia A Patients with Residual FVIII Levels...

Reding, M. T.

BIOMARIN PHARMACEUTICAL, INC.

5/1/18 → 7/15/23

Project: Research project

A Prospective Non-Interventional Study of Bleed

Reding, M. T.

BIOMARIN PHARMACEUTICAL, INC.

2/15/18 → 12/31/23

Project: Research project

ECHO: Expanding Communications on Hemophilia-A Outcomes.

Reding, M. T.

BAYER HEALTHCARE PHARMACEUTICALS

7/1/16 → 12/31/21

Project: Research project

Phase I/II/III Pharmacokinetic and Outcome Study of Insp

Reding, M. T.

Inspiration Biopharmaceuticals, Inc.

5/14/10 → 12/31/20

Project: Research project

A multi-centre, randomised, double-blinded, controlled,

Reding, M. T.

NOVO NORDISK

5/22/07 → 12/31/20

Project: Research project

Finished

Health Resources and Services Administration Grant

Reding, M. T.

Fairview Health Services

6/1/17 → 5/31/18

Project: Research project

A RANDOMIZED, MULTICENTER, OPEN-LABEL, PHASE III CLINICA

Reding, M. T.

Genentech Inc.

2/1/16 → 7/31/16

Project: Research project

A Phase III Study on the Safety, Pharmacokinetics and Ef

Reding, M. T.

REVO BIOLOGICS, INC.

6/1/14 → 5/31/18

Project: Research project

My Life Our Future: A Hemophilia Genotyping Initiative D

Reding, M. T.

AMERICAN THROMBOSIS & HEMOSTATIS NETWORK

11/1/13 → 12/31/18

Project: Research project

An Observational Study of Postoperative Deep Venous Thro

Reding, M. T.

THE UNIV. OF N. CAROLINA AT CHAPEL HILL

11/5/12 → 4/2/19

Project: Research project

A Phase 1/2 Open-Label, Single Ascending Dose Trial of a

Reding, M. T.

BAXTER HEALTHCARE CORP

9/17/12 → 12/31/16

Project: Research project

A Phase 1/2 Open-Label, Single Ascending Dose Trial of a

Reding, M. T.

ASKLEPIOS Biopharmaceutical, Inc.

5/30/12 → 5/30/17

Project: Research project

A Phase II/III, multicenter, partially randomized, open

Reding, M. T.

BAYER HEALTHCARE PHARMACEUTICALS

4/24/12 → 12/31/18

Project: Research project

Prospective, Open-Label, Multi-Center, Phase III Clinica

Reding, M. T.

OCTAPHARMA USA, INC.

3/14/12 → 3/13/17

Project: Research project

Public Health Surveillance for the Prevention of Complic

Reding, M. T.

Fairview Health Services

9/30/11 → 9/29/19

Project: Research project

Pathophysiology of anti-factor VIII inhibitor developmen

Reding, M. T.

Emory University

3/8/11 → 2/28/14

Project: Research project

Efficacy and Safety of NNC 0078-0000-0007 in Treatment o

Reding, M. T.

NOVO NORDISK

2/28/11 → 2/27/15

Project: Research project

An open-label Phase I trial to evaluate the pharmacokine

Reding, M. T.

BAYER HEALTHCARE PHARMACEUTICALS

6/1/10 → 5/31/13

Project: Research project

National Hemophilia Foundation's National Prevention Program

Reding, M. T.

NATL HEMOPHILIA FDN

10/15/08 → 12/31/10

Project: Research project

Dosing Observational Study In Hemophilia Subjects with I

Reding, M. T.

Outcome Sciences, Inc.

2/22/08 → 5/31/10

Project: Research project

TMH 04: High Dose Granulocyte Transfusions for the Treat

Mc Cullough, J., Reding, M. T. & Steiner, M. E.

New England Research Institutes

1/1/08 → 12/31/13

Project: Research project

Randomized, controlled, parallel, prospective trial to e

Reding, M. T.

Pharmaceutical Product Development, Inc.

1/1/08 → 12/31/13

Project: Research project

TMH Network Master Site Agreement - HIT Observational Th

Mc Cullough, J., Reding, M. T. & Steiner, M. E.

New England Research Institutes

9/1/07 → 8/31/12

Project: Research project

MASTER: TMH Network Master Site Agreement

Mc Cullough, J., Clay, M., Reding, M. T. & Steiner, M. E.

New England Research Institutes

9/1/07 → 8/31/14

Project: Research project

Clinical Trials in Transfusion Medicine and Hemostasis

Mc Cullough, J., Clay, M. & Reding, M. T.

NIH NAT'L HEART, LUNG, AND BLOOD INSTITU

9/1/07 → 8/31/14

Project: Research project

Determination of the Optimal Prophylactic Platelet Dose

Mc Cullough, J., Reding, M. T. & Steiner, M. E.

New England Research Institutes

9/1/07 → 8/31/12

Project: Research project

Strategies to Prevent the Complications of Hemophilia

Reding, M. T.

GREAT LAKES HEMOPHILIA FDN

9/30/06 → 9/29/11

Project: Research project

BOEC and SBTn for Gene Therapy

Hebbel, R. P., Key, N., Kren, B. J., Reding, M. T. & Steer, C. J.

NATL HEMOPHILIA FDN

7/1/06 → 6/30/10

Project: Research project

Advate Antihemophilic Factor (Recombinant), Plasma/Album

Reding, M. T.

BAXTER HEALTHCARE CORP

2/16/06 → 12/31/09

Project: Research project

Upper Midwest Hemophilia Diagnostic & Treatment Center Health Resources and Services Administration Grant

Reding, M. T.

Fairview Health Services

6/1/05 → 5/31/17

Project: Research project

Lonafarnib in CMML (SPRI P-02978)

Reding, M. T.

SCHERING-PLOUGH CORPORATION

2/17/05 → 7/1/08

Project: Research project

OBI-1 Open Label

Reding, M. T.

OCTAGEN CORP

2/10/05 → 12/31/07

Project: Research project

Immune response to factor VIII following gene therapy wi

Reding, M. T.

Hemophilia of Georgia Inc

7/1/03 → 6/30/08

Project: Research project

Upper Midwest Hemophilia Diagnostic & Treatment Center

Reding, M. T.

GREAT LAKES HEMOPHILIA FDN

10/1/93 → 9/29/06

Project: Research project